Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

Volume: 381, Issue: 9, Pages: 803 - 815
Published: Aug 29, 2019
Abstract
Two drugs under consideration for inclusion in antiretroviral therapy (ART) regimens for human immunodeficiency virus (HIV) infection are dolutegravir (DTG) and tenofovir alafenamide fumarate (TAF). There are limited data on their use in low- and middle-income countries.We conducted a 96-week, phase 3, investigator-led, open-label, randomized trial in South Africa, in which we compared a triple-therapy combination of emtricitabine (FTC) and DTG...
Paper Details
Title
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
Published Date
Aug 29, 2019
Volume
381
Issue
9
Pages
803 - 815
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.